In 1967, Austrian–Brazilian immunologist Ruth Nussenzweig made a momentous discovery. By blasting malaria parasites with radiation, she could weaken them. When injected into mice, these feeble ...

Antibodies that bind to a previously untargeted portion of the malaria parasite could lead to new monoclonal antibody treatments and vaccines for malaria. A novel class of antibodies that binds to a ...

A novel class of antibodies has been discovered that binds to a previously untargeted portion of the malaria parasite—a cryptic pGlu-CSP site on the Plasmodium falciparum (Pf) sporozoite surface. The ...

A new malaria vaccine showed encouraging results in a phase 1 study conducted in Bamako, Mali, West Africa, a region where malaria remains a year-round threat to public health. Published in NEJM ...

We in the global malaria community are at a critical juncture in our journey toward malaria eradication. Decades of experience in deploying our existing interventions have made it clear that there is ...

New research co-led by Burnet Institute and WEHI has uncovered how the human immune system fights Plasmodium vivax, paving the way for the first effective vaccine against the most widespread form of ...

Please provide your email address to receive an email when new articles are posted on . In a human challenge trial, the GA2 vaccine prevented 89% of people who received it from being infected with ...

Every cell of the deadly Plasmodium falciparum parasite, the organism that causes malaria, contains a tiny compartment full of microscopic iron crystals. As long as the parasite is alive, the crystals ...

A novel class of antibodies that binds to a previously untargeted portion of the malaria parasite could lead to new prevention methods, according to a study from researchers at the National Institutes ...